Success Stories: Our Team Helped an Associate Research Scientist from Russia to Secure NIW Petition Approval in 8 Months

 

Client’s Testimonial:

“Thank you very much for your help with the case preparation! I really appreciate your guidance and advice throughout the process.”


On May 20th, 2021, we received another EB-2 NIW (National Interest Waiver) approval for an Associate Research Scientist in the Field of Radiation Medicine (Approval Notice).


General Field: Radiation Medicine

Position at the Time of Case Filing: Associate Research Scientist

Country of Origin: Russia

State of Residence at the Time of Filing: New York

Approval Notice Date: May 20th, 2021

Processing Time: 8 months


Case Summary:

An associate research scientist approached us to file an EB-2 NIW (National Interest Waiver) petition on her behalf. Our client held a Ph.D. in medical science and tremendous knowledge in the field of radiation medicine and hired North America Immigration Law Group as she was acquainted with the fact that we would go beyond to lead her to NIW approval successfully. Thus, we began preparing her case with the provided documents, and we confirmed the veracity of her credentials by including the following required information in her petition packet:

We established that our client’s research work is relevant to improving treatment for cancer and reducing the impact of radiation exposure in the United States since it focused on determining the mechanisms behind genetic disorders that lead to cancer, improving high-throughput bio dosimetry for radiation screening, and determining genetic factors involved in radiation sensitivity. Moreover, her research has been supported with funding from the Ministry of Education, Culture, Sports, Science and Technology of Japan, Ministry of Health, Labor and Welfare of Japan, Naito Foundation, Takeda Science Foundation, Tsuchiya Medical Foundation, Japan Science and Technology Agency, Japan Agency for Medical Research and Development, Mochida Memorial Foundation for Medical and Pharmaceutical Research, Ono Medical Research Foundation, National Institutes of Health. Therefore, this is an unusually strong record of success for a researcher in radiation medicine and demonstrates her ability to continue pursuing her proposed work here in the U.S., also, confirming that funding from such prominent public agencies speaks to the great scientific and societal value of her research.

We noted our client’s impressive record of publication and citation count, which are 102 citations gathered from the 4 peer-reviewed journal articles (3 of them first-authored) she published in no fewer than 2 highly ranked peer-reviewed journals. Besides, we incorporated four recommendation letters in her petition packet to solidify the case, corroborating that her research has important implications in identifying the causes of cancers leading to new cancer treatments that focus upon defective cilia biogenesis and genetic changes, thus indicating that her work is of national importance. One of the recommenders also stated:

“[Client’s] research drastically reduces the time necessary to diagnose exposures, saving countries from the economic burden of a nuclear accident as well as saving the lives of people in danger of acute radiation sickness or increased likelihood of cancer. By creating a new method of blood testing for elevated radiation levels, her research tests more people at a faster rate than any methods have previously, making her project indispensable to keeping international populations safe, healthy, and productive in the future.”

We are so happy that our client received her NIW approval as our law firm is especially known for the vigilance our team members have while filing employment-based visa petitions. We genuinely thank her for contacting us and allowing us to present her NIW case to the USCIS on her part. Also, we would like to congratulate her on achieving this breakthrough in her chosen field of radiation medicine.